Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.91%33.52B | 5.88%136.3B | 10.79%33.22B | 11.48%128.74B | 13.83%31.74B | 9.66%33.61B | 13.72%33.4B | 8.74%29.98B | 11.01%115.48B | -0.24%27.88B |
| Cost of revenue | -0.70%25.11B | 5.24%102.54B | 9.19%25.29B | 9.09%97.43B | 8.92%23.02B | 7.90%25.5B | 10.79%25.75B | 8.73%23.16B | 15.59%89.31B | -0.98%21.14B |
| Gross profit | 6.04%8.41B | 7.85%33.76B | 16.25%7.93B | 19.63%31.3B | 29.22%8.72B | 15.61%8.12B | 24.77%7.65B | 8.77%6.82B | -2.21%26.17B | 2.15%6.75B |
| Operating expense | 0.57%6.57B | 5.76%26.66B | 10.35%6.54B | 8.03%25.21B | 16.17%6.67B | 7.21%6.28B | 5.16%6.34B | 3.73%5.92B | 7.49%23.34B | 1.90%5.75B |
| Staff costs | ---- | 7.76%9.64B | ---- | 10.40%8.95B | ---- | ---- | ---- | ---- | 5.91%8.11B | ---- |
| Selling and administrative expenses | ---- | 5.14%5.42B | ---- | 2.26%5.16B | ---- | ---- | ---- | ---- | 2.50%5.04B | ---- |
| -General and administrative expense | ---- | 5.14%5.42B | ---- | 2.26%5.16B | ---- | ---- | ---- | ---- | 2.50%5.04B | ---- |
| Research and development costs | ---- | 11.63%2.53B | ---- | 5.75%2.26B | ---- | ---- | ---- | ---- | 13.84%2.14B | ---- |
| Depreciation and amortization | ---- | 1.21%1.59B | ---- | 1.82%1.57B | ---- | ---- | ---- | ---- | 8.06%1.54B | ---- |
| -Depreciation | ---- | 1.21%1.59B | ---- | 1.82%1.57B | ---- | ---- | ---- | ---- | 8.06%1.54B | ---- |
| Rent and land expenses | ---- | 0.09%1.12B | ---- | 2.20%1.12B | ---- | ---- | ---- | ---- | -3.96%1.09B | ---- |
| Other operating expenses | ---- | 3.41%6.37B | ---- | 13.72%6.16B | ---- | ---- | ---- | ---- | 15.38%5.42B | ---- |
| Operating profit | 31.80%1.83B | 16.51%7.1B | 55.31%1.39B | 115.27%6.09B | 103.99%2.05B | 58.00%1.84B | 1,128.97%1.32B | 60.39%895M | -43.94%2.83B | 3.62%1B |
| Net non-operating interest income (expenses) | 25.94%-257M | 10.86%-1.21B | -5.47%-347M | -54.98%-1.35B | 16.08%-261M | -66.81%-377M | -105.32%-386M | -122.30%-329M | -61.67%-873M | -150.81%-311M |
| Non-operating interest income | 17.50%94M | 60.22%447M | 73.91%80M | 160.75%279M | 186.67%129M | 163.16%50M | 145.45%54M | 119.05%46M | 33.75%107M | 9.76%45M |
| Non-operating interest expense | -17.80%351M | 1.29%1.65B | 13.87%427M | 66.53%1.63B | 9.55%390M | 74.29%427M | 109.52%440M | 121.89%375M | 58.06%980M | 115.76%356M |
| Net investment income | -156.35%-142M | -43.44%293M | 43.18%252M | 6.80%518M | 40.00%84M | 500.00%6M | 44.00%252M | -29.32%176M | 61.13%485M | -65.32%60M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 210M | 0 | |||||||
| Income from associates and other participating interests | -53.49%20M | 2.13%240M | 13.16%43M | 35.06%235M | 41.07%79M | 281.25%29M | -9.18%89M | 5.56%38M | 61.11%174M | 75.00%56M |
| Special income (charges) | -202.67%-227M | 96.37%-75M | 32.43%-75M | -205.01%-2.07B | -111M | |||||
| Less:Other special charges | ---- | 202.67%227M | ---- | 38.89%75M | ---- | ---- | ---- | ---- | -75.68%54M | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 341.67%2.01B | --57M |
| Other non-operating income (expenses) | 0.00%13M | 51.33%628M | -80.88%13M | 18.23%415M | 70.00%238M | -91.14%14M | -3.06%95M | 251.11%68M | 142.07%351M | 122.22%140M |
| Income before tax | 8.51%1.47B | 12.99%6.82B | 59.25%1.35B | 574.41%6.04B | 177.91%2.32B | 39.34%1.51B | 181.52%1.36B | 30.41%849M | -79.56%895M | 94.17%833M |
| Income tax | -1.84%694M | 23.14%3.19B | 48.53%707M | 6.37%2.59B | -2.48%393M | 22.54%984M | -1.60%736M | -0.83%476M | 29.19%2.43B | 32.57%403M |
| Net income | 19.88%772M | 5.34%3.63B | 72.65%644M | 323.98%3.45B | 346.98%1.92B | 87.50%525M | 125.92%627M | 119.41%373M | -161.71%-1.54B | 244.00%430M |
| Net income continuous operations | 19.84%773M | 5.37%3.63B | 72.92%645M | 323.98%3.45B | 346.98%1.92B | 87.50%525M | 125.91%627M | 118.13%373M | -161.68%-1.54B | 244.00%430M |
| Noncontrolling interests | 1.13%179M | 3.76%911M | -12.81%177M | 31.44%878M | 7.98%284M | 16.11%209M | 54.24%182M | 89.72%203M | 11.89%668M | 54.71%263M |
| Net income attributable to the company | 26.77%592M | 5.88%2.72B | 176.33%467M | 216.35%2.57B | 880.84%1.64B | 216.00%316M | 117.57%446M | 168.25%169M | -216.39%-2.21B | 479.55%167M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 26.77%592M | 5.88%2.72B | 176.33%467M | 216.35%2.57B | 880.84%1.64B | 216.00%316M | 117.57%446M | 168.25%169M | -216.39%-2.21B | 479.55%167M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 27.14%12.6 | 5.87%57.7 | 175.28%9.91 | 215.83%54.5 | 865.00%34.74 | 207.80%6.71 | 117.44%9.45 | 166.67%3.6 | -215.60%-47.05 | 467.35%3.6 |
| Diluted earnings per share | 27.14%12.6 | 5.87%57.7 | 175.28%9.91 | 215.83%54.5 | 879.99%34.74 | 213.60%6.7041 | 117.42%9.45 | 166.67%3.6 | -215.60%-47.05 | 461.73%3.545 |
| Dividend per share | 0 | 20.00%18 | 0 | 25.00%15 | 550.00%13 | 0 | -80.00%2 | 0 | -52.00%12 | -86.67%2 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |